Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empiric Calcium in Massive Transfusion Trauma Patients
NCT05953376Phase 3Withdrawn
- Sponsor
- University of California, Irvine
- Start
- Jan 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of calcium gluconate in hemorrhage, hypocalcemia and hemorrhagic shock (2 arms), sponsored by University of California, Irvine. Primary endpoint: Transfusion requirements at 24 hours. Planned start Jan 2025; status: withdrawn.
02
Drugs
calcium gluconate
03
Conditions
hemorrhagehypocalcemiahemorrhagic shock
Beyond the preview
Go deeper on NCT05953376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05953376.